Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Camostat Mesilate + Hydroxychloroquine in Moderate COVID-19
NCT04338906Phase 4Withdrawn
- Sponsor
- Heinrich Heine University Düsseldorf
- Start
- May 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of camostat mesilate in coronavirus disease 2019 (COVID-19), sponsored by Heinrich Heine University Düsseldorf. Planned start May 2020; status: withdrawn.
02
Drugs
camostat mesilate
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04338906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04338906.